Isolate Data
| Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
| GV-30 | Vent30B | Italy | 1997 | HIV1 | B | PBMC | None |
Treatment History
| Order | Regimen | Weeks |
| 1 | AZT | NA |
RT Sequence
| NRTIMajorDRMs | NRTIMinorDRMs | NNRTIMajorDRMs | NNRTIMinorDRMs | Polys | UnusualMuts |
| T215D | A98G | R83K, K103X, K122E, D123E, I167X, D177E, I178M, T200A, R211K |
| >Vent30B| codons 30-229 KIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFRELNKKTQDFWE VQLGIPHPGGLKKXKSVTVLDVGDAYFSVPLDEEFRKYTAFTIPSINNETPGIRYQYNVL PQGWKGSPAIFQSSMTKXLEPFRKQNPEMVIYQYMDDLYVGSDLEIGQHRAKIEELRQHL LKWGFDTPDKKHQKEPPFLW |
References
| Author | Title | Citation |
| Venturi, G | Genotypic resistance to zidovudine as a predictor of failure of subsequent therapy with human immunodeficiency virus type-1 nucleoside reverse-transcriptase inhibitors. | Eur J Clin Microbiol Infect Dis, 1999 |
| Rhee, SY | HIV-1 protease and reverse transcriptase mutations: Correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillance. | J Infect Dis, 2005 |